Danaher partners with NVIDIA: TD Cowen raises target for Danaher stock to USD 255

Published on 10/19/2026 at 09:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 5.50 percent to USD 6.26 billion in the second quarter. Danaher stock costs EUR 205.20 on October 19, 2026 before October 21 results.

Events and earnings dates

Danaher and NVIDIA announced their autonomous science collaboration on October 14, 2026.
Second-quarter revenue rose 5.50 percent year over year to USD 6.26 billion.
Danaher stock traded at EUR 205.20 at 9:12 a.m. CEST at Lang & Schwarz on October 19, 2026.

Börsen-Editorial des NYSE-Handelsplatzes mit DHR-Ticker und Life-Sciences-Kursdiagrammen — Danaher Corp. NYSE-Handelsparkett US2358511028 mit DHR-Ticker-Kursanzeige und sektorspezifischen Life-Sciences-Charts auf mehreren Bildschirmen, Illustration mit AI erstellt.

Danaher Corp. (ISIN US2358511028) was trading pre-market at EUR 205.20 at Lang & Schwarz on October 19, 2026 at 9:12 a.m. CEST. On October 14, Danaher announced a collaboration with NVIDIA to connect artificial intelligence, laboratory instruments and experimental data. Business Insider reported on October 13 that TD Cowen raised its price target from USD 236.00 to USD 255.00.

AI collaboration sets the latest theme

The NVIDIA initiative is aimed at autonomous science rather than a single product launch. Initial work covers selected instruments, laboratory workflow software, accelerated analytics and real-time inference, with potential expansion across Danaher's broader portfolio.

The collaboration has no disclosed financial terms, so its immediate investment relevance rests on execution. Danaher is combining a large installed instrument base with NVIDIA computing tools, while the company prepares to report third-quarter results.

What does earnings need to show?

Danaher's second-quarter 2026 revenue reached USD 6.265 billion, up 5.50 percent from USD 5.94 billion in the prior-year quarter, while net income was USD 870.0 million. The figures come from the quarter ended June 26, 2026, and give investors a concrete benchmark for the October report.

According to Business Insider, the quarter also produced adjusted earnings per share of USD 1.94 versus a USD 1.85 consensus estimate. That comparison matters because Danaher's next results will test whether improving demand is reaching the wider portfolio.

Three dates frame the next move

Danaher scheduled its third-quarter 2026 earnings call for October 21, 2026, after announcing the date on September 22. On October 9, it appointed Daniel L. Comas and Robert Hershberg to the board, which now has 13 members. On October 14, it announced the NVIDIA collaboration, making the AI initiative the latest dated corporate event.

Dates investors can mark

The next substantiated company date is October 21, 2026, for third-quarter results and the earnings call. The regular quarterly dividend of USD 0.40 per share is scheduled for payment on October 30, 2026, according to Danaher's investor press-release page.

Stock context before results

Danaher is a healthcare company focused on biotechnology, diagnostics and life sciences. Its primary listing is on the NYSE under ticker DHR, and the finance profile identifies its industry as medical diagnostics and research. The market capitalization was USD 161.0 billion on October 16, 2026, while the 52-week range was USD 160.93 to USD 242.80.

The company therefore enters the earnings date with two distinct tests: whether second-quarter growth continues and whether the NVIDIA collaboration can become a practical productivity tool. The current euro indication places the next announcement ahead of the October 21 results date.

Price and earnings date

Danaher was trading at EUR 205.20 at Lang & Schwarz on October 19, 2026 at 9:12 a.m. CEST in pre-market trading. The further course of trading is shown by the continuously updated real-time quote of Danaher stock.